They also consistently looking for new enrollees who have aniridia and do not yet know the genetic cause. Do you have aniridia with a known FOXC1 mutation? Or is the genetic cause of your aniridia still unknown? If either of these is true, you may be eligible for a research study at the Medical College …
In 2025, Aniridia North America strengthened global connections, expanded patient education, and deepened research collaboration across the aniridia community. From hosting our international symposium to answering more than 100 patient questions during Focal Point episodes and building new research partnerships, this year reflects meaningful progress for patients, families, clinicians, and scientists alike. We’re proud to …
Guest: Ali Djalilian, MD Ali Djalilian, MD is a cornea specialist and a clinician-scientist. He is the Searls-Schenk Professor of Ophthalmology at University of Illinois at Chicago. He completed fellowships with Dr Edward Holland at Cincinnati Eye Institute and at the National Eye Institute. He has an active clinical interest in limbal stem cell disease, …
Aniridia North America (ANA) announces its biennial scientific event to strengthen and expand research focused on aniridia and related problems. The 2025 Aniridia North America Symposium: PAX6, Aniridia, and Beyond will bring together top researchers from around the world for the presentation and discussion of innovative and often unpublished research at the forefront of understanding …
Guest: Albert Cheung, MD Dr. Albert Cheung is part of the skilled Cornea team at Virginia Eye Consultants in Norfolk, VA. Dr. Cheung joined VEC to provide world-class corneal and cataract care to patients. He offers advanced medical and surgical options for corneal diseases such as Fuchs dystrophy, Keratoconus, and severe ocular surface disease. He …
The ANA Board of Directors is looking forward to another great year in 2025. The infographic below highlights some goals set for 2025.
Thank you to all who supported and donated to ANA in 2024. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2025.
Here is a snapshot of the accomplishments from 2024 complete with links to information as appropriate.
ANA’s Board of Directors welcomes new member Michael Schain. Michael was born with sporadic aniridia and has a passion for improving outcomes for people with aniridia. For the past two years, he has served on the ANA Patient and Family Advisory Board. “We are so pleased to have Michael join our team,” said Peter Netland, ANA Board Chair. …
Guest: John Freeman, MD Dr. Freeman is Board Certified by the American Board of Ophthalmology and specializes in cataract surgery and corneal disease. Prior to receiving his medical degree, Dr. Freeman received his B.A. in English from Davidson College in North Carolina. Dr. Freeman earned his Medical Degree from the University of Tennessee College of …
ANA desires to increase collaboration internationally and serve as a collective voice of North American stakeholders to the international aniridia community. In pursuit of that vision, representatives from ANA were honored to be invited to and to participate in the 7th European Aniridia Conference, hosted by Aniridia Sweden, together with Linkoping University and Aniridia Europe. The …
Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525
Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.
EIN: 86-2917141
